J&J Family of Companies Director, Immunology Translational Medicine (Early Clinical Development) in Spring House, Pennsylvania
Janssen Research and Development, L.L.C., a member of Johnson and Johnson's Family of Companies, is recruiting for a Director, Immunology Translational Medicine (Early Clinical Development) to be located in Spring House, PA.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
Janssen Research & Development, LLC discovers and develops innovative medical solutions to address important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Please visit http://www.JanssenRnD.com for more information.
We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
The Director, Immunology Translational Medicine (ITM), will be primarily responsible for developing and implementing innovative, scientifically rigorous, well designed, and time-efficient Early Development Plans and disease strategies which further the Immunology Therapeutic Area’s (ITA) goal of benefitting patients with immune-mediated diseases. This includes designing and executing optimal first-in-human (FIH) and proof-of-concept (POC) studies within the ITA. This position will play a ‘dual role’, contributing both scientific as well as clinical development expertise to ITM projects. This work will include support for primarily Phase 0-2 studies.
ITM is an integrated group of scientists that includes a systems pharmacology and biomarkers group, and a clinical group which conducts early clinical development and experimental medicine studies. Janssen Immunology has a history of bringing life-changing therapies to patients with immune-mediated diseases. The ITM group will provide the key learnings/insights on the next wave of novel therapies for these patients. We are looking for a PhD level scientist with a strong Immunology background to join this collaborative research group, and help us bring these new therapies to patients.
Lead a cross-functional team to design Early Development Plans and identify appropriate FIH, proof-of-mechanism (POM) and POC study designs for new molecular entity (NME) early development programs.
Implement approved strategies for early development of NME's including FIH/POM/POC studies and for new indication assessment of compounds in development
Design, conduct, analyze and report results on assigned clinical trials, including responsibility for protocol writing.
Be an ITM ambassador within and outside of the ITA.
Qualifications for the Director include:
PhD with previous clinical research experience preferred. Either a minimum of 5 years industry experience or considerable clinical trials experience in an academic setting is preferred.
Strong experience in a relevant immunology/inflammation disease area such as GI/Inflammatory Bowel Disease, Rheumatology or Clinical Immunology is preferred.
Strong Immunology scientific expertise is preferred.
A record of peer reviewed publication and experience in scientific presentations is preferred.
The ability to work in a matrix organization with cross-functional teams is required.
The ability to travel up to 10%, including international travel is required.
United States-Pennsylvania-Spring House
Janssen Research & Development, LLC. (6084)